Genetics Frontiers

Explore breakthrough studies and innovative genomic research

Research Articles

Bomedemstat: A New Horizon of Hope for Advanced Myelofibrosis

Bomedemstat (IMG-7289), an orally active LSD1 inhibitor, shows promising results in treating advanced myelofibrosis in Phase 2 clinical trials.

Isaac Henderson
Nov 03, 2025

Popular Articles